TL;DR: Serinus Biosciences is a Y Combinator Summer 2022 startup Combinations therapy by rational design, currently active with a team of 6.
Combinations therapy by rational design
Last verified:
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.
Built by LemStudio
Yes. Serinus Biosciences was funded by Y Combinator in the Summer 2022 batch. Combinations therapy by rational design
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, ou…
Serinus Biosciences was part of Y Combinator's Summer 2022 batch.
Serinus Biosciences has a team of 6 people according to Y Combinator's directory.
Serinus Biosciences is currently listed as Active with a team of 6 in Y Combinator's directory.
Loading interactive view…